Large Simple Neuroprotective Trials in Parkinson's Disease

本临床中心申请的目的是将帕金森研究所的资格描述为 参与RFA中提出的帕金森病神经保护治疗的大型简单试验- NS-02-010。帕金森研究所有一个支持性的研究环境，广泛的临床试验， 经验丰富的高素质工作人员，以及招募临床试验志愿者的经验 和支持团体的良好关系。研究所员工拥有80多年的 临床试验经验，主要研究帕金森病的治疗方法。帕金森 研究所在通过医生从大量患者人群中招募方面具有相当丰富的经验， 通过支助小组联系人、媒体和教育活动进行联系。帕金森研究所 在临床试验实施的管理方面有良好的记录，包括受试者 安全性、信息保密性、及时入组受试者、及时完成研究资料 和数据完整性。这些特点使帕金森研究所成为一个理想的参与者， 拟议的审判。

The goal of this clinical center application is to describe the qualifications of the Parkinson's Institute as a participant in the large simple trial of neuroprotective therapy for Parkinson's disease as proposed in RFA- NS-02-010. The Parkinson's Institute has a supportive research environment, extensive clinical trials experience and highly qualified staff, together with experience in the recruitment of clinical trials volunteers and an excellent relationship with support groups. Institute staff have more than 80 years of combined experience in clinical trials, primarily investigating therapies for Parkinson's disease. The Parkinson's Institute has considerable experience in recruitment from a large patient population, through physician contacts, through support groups contacts, media and educational activities. The Parkinson's Institute has an excellent track record regarding the administrative aspects of clinical trials conduct, including subject safety, confidentiality of information, timely enrollment of subjects, timely completion of study materials and data integrity. These characteristics make the Parkinson's Institute an ideal participant in the proposed trial.